Scarica l'app Stockscreener
137.64
0.98%
1.34
Dopo l'orario di chiusura:
137.64
Precedente Chiudi:
$136.30
Aprire:
$136.78
Volume 24 ore:
524.52K
Relative Volume:
0.70
Capitalizzazione di mercato:
$8.35B
Reddito:
$4.09B
Utile/perdita netta:
$-404.84M
Rapporto P/E:
-20.40
EPS:
-6.7469
Flusso di cassa netto:
$1.24B
1 W Prestazione:
-0.64%
1M Prestazione:
+4.43%
6M Prestazione:
+17.68%
1 anno Prestazione:
+25.09%
Intervallo 1D:
$135.63
$138.31
Intervallo di 1 settimana:
$133.45
$140.00
Portata 52W:
$95.49
$148.06
Jazz Pharmaceuticals Plc Stock (JAZZ) Company Profile
Nome
Jazz Pharmaceuticals Plc
Settore
Industria
Telefono
353-1-634-7800
Indirizzo
FIFTH FLOOR, WATERLOO EXCHANGE, DUBLIN
Confronta JAZZ con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
JAZZ
Jazz Pharmaceuticals Plc
|
137.64 | 8.27B | 4.09B | -404.84M | 1.24B | -6.7469 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.57 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
651.80 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.04 | 58.93B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
818.50 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.60 | 41.29B | 447.02M | -1.18B | -868.57M | -6.1812 |
Jazz Pharmaceuticals Plc Stock (JAZZ) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-07-15 | Iniziato | Deutsche Bank | Buy |
| 2025-03-07 | Aggiornamento | UBS | Neutral → Buy |
| 2025-02-26 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| 2025-02-13 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2024-12-12 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2024-06-05 | Iniziato | Goldman | Buy |
| 2024-01-03 | Iniziato | Robert W. Baird | Outperform |
| 2023-11-27 | Downgrade | UBS | Buy → Neutral |
| 2023-09-29 | Iniziato | Raymond James | Mkt Perform |
| 2023-06-12 | Ripresa | Wells Fargo | Equal Weight |
| 2022-12-09 | Aggiornamento | Goldman | Neutral → Buy |
| 2022-06-14 | Iniziato | UBS | Buy |
| 2022-04-06 | Downgrade | Goldman | Buy → Neutral |
| 2021-11-19 | Ripresa | Goldman | Buy |
| 2021-10-07 | Ripresa | Jefferies | Buy |
| 2021-10-05 | Iniziato | Citigroup | Buy |
| 2021-09-23 | Iniziato | Needham | Buy |
| 2021-05-19 | Ripresa | JP Morgan | Overweight |
| 2021-04-07 | Ripresa | RBC Capital Mkts | Outperform |
| 2021-02-05 | Reiterato | H.C. Wainwright | Buy |
| 2021-02-03 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2021-01-29 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2020-12-16 | Iniziato | UBS | Buy |
| 2020-11-03 | Reiterato | H.C. Wainwright | Buy |
| 2020-10-09 | Reiterato | H.C. Wainwright | Buy |
| 2020-09-14 | Downgrade | Goldman | Neutral → Sell |
| 2020-09-14 | Ripresa | JP Morgan | Overweight |
| 2020-08-06 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2020-07-28 | Aggiornamento | Wolfe Research | Peer Perform → Outperform |
| 2020-07-23 | Aggiornamento | H.C. Wainwright | Neutral → Buy |
| 2020-04-06 | Iniziato | Jefferies | Buy |
| 2020-03-12 | Aggiornamento | Bernstein | Mkt Perform → Outperform |
| 2020-01-08 | Iniziato | Goldman | Neutral |
| 2019-08-21 | Downgrade | Piper Jaffray | Overweight → Neutral |
| 2019-06-11 | Iniziato | Barclays | Overweight |
| 2019-03-20 | Iniziato | SunTrust | Buy |
| 2018-12-14 | Iniziato | Wolfe Research | Peer Perform |
| 2018-11-08 | Reiterato | B. Riley FBR | Buy |
| 2018-08-08 | Reiterato | Stifel | Buy |
| 2018-07-11 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2018-03-23 | Reiterato | H.C. Wainwright | Neutral |
| 2018-03-19 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
Mostra tutto
Jazz Pharmaceuticals Plc Borsa (JAZZ) Ultime notizie
What Jazz Pharmaceuticals (JAZZ)'s Cross-Licensing Settlement With Avadel Means For Shareholder Value - Yahoo! Finance UK
Why Jazz Pharmaceuticals plc stock is trending among retail tradersJuly 2025 Closing Moves & AI Powered Buy/Sell Recommendations - newser.com
Can Jazz Pharmaceuticals plc stock hit record highs againPortfolio Update Summary & Smart Investment Allocation Insights - newser.com
Assetmark Inc. Purchases 82,275 Shares of Jazz Pharmaceuticals PLC $JAZZ - MarketBeat
Are Jazz Pharmaceuticals Shares Still Attractive After a 25% Climb and New Pipeline Developments? - simplywall.st
Why Jazz Pharmaceuticals plc (J7Z) stock could be next leaderJuly 2025 Closing Moves & Precise Buy Zone Tips - newser.com
Multi factor analysis applied to Jazz Pharmaceuticals plc2025 Market Overview & AI Forecast for Swing Trade Picks - newser.com
How Jazz Pharmaceuticals plc stock trades during market volatilityJuly 2025 Spike Watch & Growth Focused Investment Plans - newser.com
Jazz Pharmaceuticals PLC $JAZZ Shares Purchased by Kovack Advisors Inc. - MarketBeat
Statistical indicators supporting Jazz Pharmaceuticals plc’s strengthJuly 2025 Setups & AI Enhanced Trading Signals - newser.com
Impact Partnership Wealth LLC Takes Position in Jazz Pharmaceuticals PLC $JAZZ - MarketBeat
When is the best time to exit Jazz Pharmaceuticals plcJuly 2025 Outlook & Low Risk High Win Rate Picks - newser.com
How Investors May Respond To Jazz Pharmaceuticals (JAZZ) Settling Global LUMRYZ Patent Dispute with Avadel - simplywall.st
Best data tools to analyze Jazz Pharmaceuticals plc stock2025 Market Overview & Reliable Volume Spike Alerts - newser.com
Is Jazz Pharmaceuticals plc (J7Z) stock a momentum leaderTrade Ideas & Long-Term Investment Growth Plans - newser.com
How strong is Jazz Pharmaceuticals plc stock revenue growthTrade Risk Assessment & Fast Gain Stock Tips - newser.com
Why Jazz Pharmaceuticals plc stock is seen as undervalued2025 Growth vs Value & AI Powered Market Entry Strategies - newser.com
Jazz Pharmaceuticals plc stock outlook for YEARJuly 2025 Outlook & Fast Entry High Yield Tips - newser.com
Is Jazz Pharmaceuticals plc stock a buy before product launchesJuly 2025 Summary & Daily Technical Forecast Reports - newser.com
Jazz Pharmaceuticals plc (JAZZ) Analyst insights, Price targets and Recommendations - Yahoo! Finance UK
Jazz Pharmaceuticals (JAZZ) Expected to Announce Quarterly Earnings on Wednesday - MarketBeat
Jazz Pharmaceuticals PLC (NASDAQ:JAZZ) Given Consensus Recommendation of "Moderate Buy" by Analysts - MarketBeat
Will Jazz Pharmaceuticals plc stock see PE expansionWeekly Profit Recap & High Win Rate Trade Tips - newser.com
Jazz Pharmaceuticals plc (JAZZ) Stock forecasts - Yahoo! Finance UK
What Technical Volume Patterns Indicate for Hinduja Global Solutions LimitedLong-Term Investment Plans & High Yield Investment Portfolio - earlytimes.in
Jazz Pharmaceuticals plc (JAZZ) Stock Forecasts - Yahoo Finance
JAZZ (Jazz Pharmaceuticals) Forward Rate of Return (Yacktma - GuruFocus
Earnings Preview: Jazz Pharmaceuticals (JAZZ) Q3 Earnings Expected to Decline - Yahoo Finance
Jazz Pharmaceuticals Appoints Ted W. Love, M.D., to its Board of Directors - The AI Journal
Jazz Pharmaceuticals Announces Board Changes - TradingView
JAZZ appoints Dr. Ted Love to Board, sets term to 2027 AGM - Stock Titan
Jazz Pharmaceuticals plc Announces Board Changes, Effective December 1, 2025 - MarketScreener
Jazz Pharmaceuticals (NASDAQ:JAZZ) Given New $199.00 Price Target at JPMorgan Chase & Co. - MarketBeat
Zymeworks Announces Participation in Upcoming Investor Conferences - GlobeNewswire Inc.
Jazz Pharmaceuticals Plc Azioni (JAZZ) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.62%
0.21%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):